Goldberg J P, Schrier R W
Miner Electrolyte Metab. 1984;10(3):178-83.
In the present study the in vivo role of transcellular calcium influx in humorally-mediated vasoconstriction was examined in conscious rats using two chemically dissimilar inhibitors of cellular calcium uptake, namely verapamil (Ver, 50 micrograms/kg/min) and nifedipine (Nif, 7.5 micrograms/kg/min). The pressor effect of arginine vasopressin (AVP, 10 mU/kg/min), angiotensin II (AII, 0.3 micrograms/kg/min) and norepinephrine (NE, 4 micrograms/kg/min) was virtually abolished by Ver and Nif. None of the pressors when infused alone increased mean arterial pressure (MAP) by increasing cardiac index (CI). During the administration of the calcium antagonists and AII or NE, CI was slightly but not significantly higher than with AII or NE alone. A modest fall in CI occurred with AVP and Ver but not with AVP and Nif. Thus, the effect of calcium antagonists to block the pressor responses of AVP, NE and AII was primarily by preventing the increase in peripheral vascular resistance rather than depressing CI. In summary, transcellular calcium influx appears to constitute the common in vivo pathway for constriction of peripheral blood vessels by AVP, NE and AII. These findings have substantial pathogenetic and therapeutic implications in hypo- and hypertensive states.
在本研究中,使用两种化学性质不同的细胞钙摄取抑制剂,即维拉帕米(Ver,50微克/千克/分钟)和硝苯地平(Nif,7.5微克/千克/分钟),在清醒大鼠中研究了跨细胞钙内流在体液介导的血管收缩中的体内作用。维拉帕米和硝苯地平几乎完全消除了精氨酸加压素(AVP,10毫单位/千克/分钟)、血管紧张素II(AII,0.3微克/千克/分钟)和去甲肾上腺素(NE,4微克/千克/分钟)的升压作用。单独输注时,这些升压药均未通过增加心脏指数(CI)来升高平均动脉压(MAP)。在给予钙拮抗剂以及AII或NE期间,CI略高于单独给予AII或NE时,但差异无统计学意义。AVP与维拉帕米联合使用时CI略有下降,但AVP与硝苯地平联合使用时CI未下降。因此,钙拮抗剂阻断AVP、NE和AII升压反应的作用主要是通过阻止外周血管阻力增加,而非降低CI。总之,跨细胞钙内流似乎是AVP、NE和AII导致外周血管收缩的共同体内途径。这些发现对低血压和高血压状态具有重要的发病机制和治疗意义。